Last reviewed · How we verify

Prilocaine (Hyperbaric 2%)

Guy's and St Thomas' NHS Foundation Trust · FDA-approved active Small molecule

Prilocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.

Prilocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses. Used for Spinal anesthesia for surgical procedures, Local infiltration anesthesia.

At a glance

Generic namePrilocaine (Hyperbaric 2%)
Also known asHyperbaric prilocaine
SponsorGuy's and St Thomas' NHS Foundation Trust
Drug classLocal anesthetic
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesia
PhaseFDA-approved

Mechanism of action

Prilocaine works by reversibly inhibiting sodium influx through voltage-gated sodium channels in nerve fibers, which prevents depolarization and action potential generation. This results in local loss of sensation in the area where it is administered. The hyperbaric formulation (2%) is prepared with dextrose to increase its specific gravity, allowing it to settle dependently in the cerebrospinal fluid when used for spinal anesthesia.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: